1. 垂体腺瘤出血性卒中的危险因素分析.
- Author
-
李卓群, 王宇翔, 杨宇浩, 尹宏伟, 崔振文, 丰育功, and 李照建
- Abstract
Objective To investigate the risk factors of hemorrhagic pituitary adenoma apoplexy. Methods The clinical date of 875 patients with non-functioning pituitary adenoma from January 2010 to January 2021 in the Department of Neurosurgery, Affiliated Hospital of Qingdao University were analyzed retrospectively. According to the occurrence of pituitary adenoma hemorrhagic stroke, the patients were divided into stroke group (88 cases) and non-stroke group (787 cases). The risk factors affecting the occurrence of pituitary adenoma hemorrhagic stroke were screened by univariate analysis and multivariate logistic regression analysis. Results The proportion of bromocriptine therapy, the history of taking antithrombotic drugs, recurrent or residual tumor, and the history of intervention operation in the patient with pituitary apoplexy were higher than those without pituitary apoplexy. The proportion of microadenoma in pituitary adenoma apoplexy group was lower than non-apoplexy group. The difference between the two groups has statistical significance (P<0.05). Multivariate logistic regression analysis indicated that macroadenoma (OR=0.189, 95%CI:0.069-0.522, P=0.001), the history of taking antithrombotic drugs (OR=4.168, 95%CI:1.611-10.785, P=0.003), bromocriptine therapy (OR=2.912, 95%CI:1.156-7.34, P=0.023) and recurrent or residual tumor (OR=2.787, 95%CI:1.179-6.59, P=0.020) were independent risk factors of pituitary apoplexy. Conclusion The risk factors of hemorrhagic pituitary apoplexy are macroadenoma, the history of taking antithrombotic drugs, bromocriptine therapy and recurrent or residual tumor. Objective To investigate the risk factors of hemorrhagic pituitary adenoma apoplexy. Methods The clinical date of 875 patients with non-functioning pituitary adenoma from January 2010 to January 2021 in the Department of Neurosurgery, Affiliated Hospital of Qingdao University were analyzed retrospectively. According to the occurrence of pituitary adenoma hemorrhagic stroke, the patients were divided into stroke group (88 cases) and non-stroke group (787 cases). The risk factors affecting the occurrence of pituitary adenoma hemorrhagic stroke were screened by univariate analysis and multivariate logistic regression analysis. Results The proportion of bromocriptine therapy, the history of taking antithrombotic drugs, recurrent or residual tumor, and the history of intervention operation in the patient with pituitary apoplexy were higher than those without pituitary apoplexy. The proportion of microadenoma in pituitary adenoma apoplexy group was lower than non-apoplexy group. The difference between the two groups has statistical significance (P<0.05). Multivariate logistic regression analysis indicated that macroadenoma (OR=0.189, 95%CI:0.069-0.522, P=0.001), the history of taking antithrombotic drugs (OR=4.168, 95%CI:1.611-10.785, P=0.003), bromocriptine therapy (OR=2.912, 95%CI:1.156-7.34, P=0.023) and recurrent or residual tumor (OR=2.787, 95%CI:1.179-6.59, P=0.020) were independent risk factors of pituitary apoplexy. Conclusion The risk factors of hemorrhagic pituitary apoplexy are macroadenoma, the history of taking antithrombotic drugs, bromocriptine therapy and recurrent or residual tumor. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF